Our experts are also using this platform to look for drug targets and therapies for other conditions. Due to an explosion in knowledge about the molecular mechanisms behind different diseases, more promising targets for the design of new drugs are being identified than ever before.
CD ComputaBio can now officially provide valuable solutions to the pharmaceutical industry via our proprietary AIDD platform. We have already seen several successful use cases via co-operation with big pharma and institutions. For more details about our solutions, please click here.
Tech Trends in Artificial Intelligence What's up, what's down, what lies ahead, only found in MedAI!